Skip to main content

Table 1 Disposition and success of updating vital status through manual record review, phone tracking, and physical tracking amongst patients newly diagnosed with Kaposi sarcoma in four countries in sub-Saharan Africa

From: Updating vital status by tracking in the community among patients with epidemic Kaposi sarcoma who are lost to follow-up in sub-Saharan Africa

 

AMPATH - Kenya

ISS - Uganda

Lighthouse- Malawi

UATH & NHA - Nigeria

Overall

Patients diagnosed with Kaposi sarcoma

678

173

314

57

1222

Presumed LTFU in EMR (D1 in Fig. 1)

249

80

75

36

440

Reclassification after manual review of LTFU in EMR

 Not truly LTFU: Vital status determined via manual review (N1b in Fig. 1)

16

1

1

0

18

 Truly LTFU but vital status determined by repeat later review of records (N1a in Fig. 1)

11

0

2

11

24

 Truly LTFU: Vital status missing after review of all records (D2 in Fig. 1)

222

79

72

25

398

Disposition of those who appear LTFU in EMR (D1 in Fig. 1)

 Vital status updated by manual records review

27/249 (11%)

1/80 (1.3%)

3/75 (4.0%)

11/36 (31%)

42/440 (9.6%)

 Vital status updated by phone contact alone

83/249 (33%)

10/80 (13%)

3/75 (4.0%)

15/36 (42%)

111/440 (25%)

 Vital status updated by physical tracking

124/249 (50%)

47/80 (59%)

22/75 (29%)

3/36 (8.3%)

196/440 (45%)

 Vital status not updated: consent available

15/249 (6.0%)

22/80 (28%)

37/75 (49%)

7/36 (19%)

81/440 (18%)

 Vital status not updated: consent not available

0/249 (0%)

0/80 (0%)

10/75 (13%)

0/36 (0%)

10/440 (2.3%)

Disposition of those who were truly LTFU (N1a + D2 in Fig. 1)

 Vital status updated by manual records review

11/233 (4.7%)

0/79 (0%)

2/74 (2.7%)

11/36 (31%)

24/422 (5.7%)

 Vital status updated by phone contact alone

83/233 (36%)

10/79 (13%)

3/74 (4.1%)

15/36 (42%)

111/422 (26%)

 Vital status updated by physical tracking

124/233 (53%)

47/79 (59%)

22/74 (30%)

3/36 (8.3%)

196/422 (46%)

 Vital status not updated: consent available

15/233 (6.4%)

22/79 (28%)

37/74 (50%)

7/36 (19%)

81/422 (19%)

 Vital status not updated: consent not available

0/233 (0%)

0/79 (0%)

10/74 (14%)

0/36 (0%)

10/422 (2.4%)

Disposition of those truly LTFU not found by manual records review (D2 in Fig. 1)

 Vital status updated by phone contact alone

83/222 (37%)

10/79 (13%)

3/72 (4.2%)

15/25 (60%)

111/398 (28%)

 Vital status updated by physical tracking

124/222 (56%)

47/79 (59%)

22/72 (31%)

3/25 (12%)

196/398 (49%)

 Vital status not updated: consent available

15/222 (6.8%)

22/79 (28%)

37/72 (51%)

7/25 (28%)

81/398 (20%)

 Vital status not updated: consent not available

0/222 (0%)

0/79 (0%)

10/72 (14%)

0/25 (0%)

10/398 (2.5%)

Disposition of those truly LTFU who were physically sought after in the community (D3 in Fig. 1)

 Vital status updated by physical tracking

124/131 (95%)

47/69 (68%)

22/35 (63%)

3/8 (38%)

196/243 (81%)

 Vital status not updated

7/131 (5.3%)

22/69 (32%)

13/35 (37%)

5/8 (63%)

47/243 (19%)

Success of tracking using combination of methods among those who consented and had sufficient information for tracking

 Records, phone contact & physical trackinga

218/225 (97%)

57/79 (72%)

27/40 (68%)

29/34 (85%)

331/378 (88%)

 Phone contact & physical trackingb

207/214 (97%)

57/79 (72%)

25/38 (66%)

18/23 (78%)

307/354 (87%)

  1. LTFU denotes lost to follow-up; EMR denotes electronic medical records; AMPATH denotes Academic Model Providing Access to Healthcare; ISS denotes Immune Suppression Syndrome; UATH denotes University of Abuja Teaching Hospital and NHA denotes National Hospital of Abuja
  2. a Success of tracking using all information available from the manual records review, telephone, and field tracking amongst those truly LTFU and who gave consent to be sought after. This is (N1a + N2 + N3) / (D1-N1b-NC-IL) in Fig. 1
  3. b Success of tracking using information available from telephone and physical tracking amongst those truly LTFU, not updated by manual review, and who gave consent to be sought after. This is (N2 + N3) / (D2-NC-IL) in Fig. 1